Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > Attn Sernova Dysfunctional Family

<< Previous

Bullboard Posts

Next >>

Comment by krikoon Jan 18, 2021 9:48am

374 Views

Post# 32318858

RE:Attn Sernova Dysfunctional Family

I am a reader (not a poster) on this board, and an original holder since Sernova was Pheromone Science and have added to my position over the past 16 years.

Apart from taking profit to cover original expense, I have not sold any shares.

This truly is a moment we've been waiting for and I also congratulate all the longs who have persevered through a decade and a half of mostly press releases that tended to have a downward impact on the share price.

Thanks to all the long-term posters who contributed valuable content (you know who you are).

All the best.

<< Previous

Bullboard Posts

Next >>

DRI Healthcare stock drops 28% after executive changes